Sunrest Lifescience
Sunrest Lifescience Performance
Day Range
- Low 67.10
- High 68.90
52 Week Range
- Low 66.40
- High 84.00
- Open Price67.60
- Previous Close67.30
- Volume16000
Start SIP in Sunrest Lifescience
Start SIPSunrest Lifescience Investment Rating
-
Master Rating:
-
Sunrest Lifescience Ltd has an operating revenue of Rs. 68.48 Cr. on a trailing 12-month basis. An annual revenue de-growth of -8% needs improvement, Pre-tax margin of 11% is healthy, ROE of 65% is exceptional. The company has a debt to equity of 64%, which is bit higher. It is currently FORMING a base in its weekly chart and is trading around 19% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 7 which is POOR indicating the underperformance as compared to other stocks, Group Rank of 154 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Mar 2022 |
|---|---|---|
| Total Revenue Annual Cr | 25 | 27 |
| Operating Expenses Annual Cr | 22 | 26 |
| Operating Profit Annual in Cr | 3 | 1 |
| Depreciation Cr | 0 | 0 |
| Interest Annual Cr | 0 | 0 |
| Tax Annual Cr | 1 | 0 |
| Net Profit Annual Cr | 2 | 1 |
Sunrest Lifescience Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
Sunrest Lifescience Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 68.90 |
| Second Resistance | 69.80 |
| Third Resistance | 70.70 |
| RSI | 0.00 |
| MFI | 0.00 |
| Support | |
|---|---|
| First Resistance | 67.10 |
| Second Resistance | 66.20 |
| Third Resistance | 65.30 |
Sunrest Lifescience Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 16,000 | 1,600,000 | 100 |
| Week | 27,200 | 2,143,904 | 78.82 |
| 1 Month | |||
| 6 Month | 7,386 | 692,474 | 93.76 |
Sunrest Lifescience Result Highlights
Sunrest Lifescience Synopsis
NSE-Medical-Supplies
Sunrest Lifescience belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 24.64 Cr. and Equity Capital is Rs. 3.00 Cr. for the Year ended 31/03/2023. Sunrest Lifescience Ltd. is a Public Limited Listed company incorporated on 30/10/2017 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U74999GJ2017PLC099606 and registration number is 099606.| Market Cap | 29 |
| Sales | 25 |
| Shares in Float | 0.43 |
| No of funds | |
| Yield |
| Book Value | 6.55 |
| U/D Vol ratio | 2.2 |
| LTDebt / Equity | 64 |
| Alpha | -1.61 |
| Beta | 0.88 |
Sunrest Lifescience
| Owner Name |
|---|
Sunrest Lifescience Management
| Name | Designation |
|---|---|
| Ms. Juhi Sawajani | Chairman(NonExe.&Ind.Director) |
| Mr. Nikhilkumar Y Thakkar | Managing Director |
| Mr. Amitbhai Shambhulal Thakkar | Whole Time Director |
| Mr. Bharatkumar V Thakkar | Executive Director |
| Mr. Bhagyesh Kiritbhai Parekh | Non Executive Director |
| Ms. Avani A Shah | Ind. Non-Executive Director |
Sunrest Lifescience Forecast
Price Estimates
Sunrest Lifescience FAQs
What is Share Price of Sunrest Lifescience ?
Sunrest Lifescience share price is ₹68 As on 11 December, 2023 | 08:43
What is the Market Cap of Sunrest Lifescience ?
The Market Cap of Sunrest Lifescience is ₹29.2 Cr As on 11 December, 2023 | 08:43
What is the P/E ratio of Sunrest Lifescience ?
The P/E ratio of Sunrest Lifescience is As on 11 December, 2023 | 08:43
What is the PB ratio of Sunrest Lifescience ?
The PB ratio of Sunrest Lifescience is 9.4 As on 11 December, 2023 | 08:43